JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'mutant idh1 inhibitor'

Search results for: 'mutant idh1 inhibitor'

A1670 Enzastaurin (LY317615)

2 Citation

Target: PKC

Summary: PKC beta inhibitor,potent and selective

insoluble in EtOH; insoluble in H2O; ≥8.59 mg/mL
A8178 Panobinostat (LBH589)

10 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in H2O; insoluble in EtOH; ≥17.47 mg/mL
A3433 Gefitinib hydrochloride

Target: EGFR

Summary: Potent EGFR inhibitor

insoluble in EtOH; ≥4.28 mg/mL
A8633 Concanamycin A

1 Citation

Target: Vacuolar-type ATPase

Summary: V-type (vacuolar) H+-ATPase inhibitor

soluble in DMSO
A4056 AT13387

Target: HSP90

Summary: Hsp90 inhibitor

insoluble in H2O; ≥13.25 mg/mL
B2266 LDE225 (NVP-LDE225,Erismodegib)

1 Citation

Target: Smoothened

Summary: Smoothened inhibitor,potent and selective

≥24.3 mg/mL
A2133 Saracatinib (AZD0530)

3 Citation

Target: Src

Summary: Src/Abl inhibitor,potent and selective

≥27.1 mg/mL
A8214 AZD8055

2 Citation

Target: mTOR

Summary: MTOR inhibitor

≥23.3 mg/mL
A4096 Belinostat (PXD101)

2 Citation

Target: Histone Deacetylases (HDACs)

Summary: Hydroxamate-type HDAC inhibitor

insoluble in H2O; ≥15.92 mg/mL
A8325 Tivantinib (ARQ 197)

2 Citation

Target: MET

Summary: C-Met inhibitor,non-ATP-competitive

≥18.47 mg/mL